Leads Biolabs-B (09887) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Dividend

Bulletin Express03-17 16:43

Nanjing Leads Biolabs Co., Ltd. (stock name: Leads Biolabs-B; stock code: 09887) has announced that its board of directors will convene on Friday, 27 March 2026. The agenda includes:

1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025. 2. Discussion and potential recommendation of a dividend distribution for shareholders.

The announcement, dated 17 March 2026, was authorized by Dr. Kang Xiaoqiang, who serves as Chairman, Executive Director and Chief Executive Officer.

Board composition as at the announcement date: • Executive Directors – Dr. Kang Xiaoqiang, Dr. Lai Shoupeng, Mr. Zuo Honggang • Non-executive Directors – Mr. Zhang Yincheng, Dr. Chen Renhai, Dr. Ni Jia • Independent Non-executive Directors – Dr. Zhang Hongbing, Mr. Du Yilong, Ms. Du Jiliu

The company will release further details following the board’s deliberations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158227991?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158227991","market":"hk","top_or_hot":-1,"title":"Leads Biolabs-B (09887) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Dividend","media":"Bulletin Express","content":"<p>Nanjing Leads Biolabs Co., Ltd. (stock name: Leads Biolabs-B; stock code: 09887) has announced that its board of directors will convene on Friday, 27 March 2026. The agenda includes:</p>\n<p>1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n2. Discussion and potential recommendation of a dividend distribution for shareholders.</p>\n<p>The announcement, dated 17 March 2026, was authorized by Dr. Kang Xiaoqiang, who serves as Chairman, Executive Director and Chief Executive Officer.</p>\n<p>Board composition as at the announcement date:  \n• Executive Directors – Dr. Kang Xiaoqiang, Dr. Lai Shoupeng, Mr. Zuo Honggang  \n• Non-executive Directors – Mr. Zhang Yincheng, Dr. Chen Renhai, Dr. Ni Jia  \n• Independent Non-executive Directors – Dr. Zhang Hongbing, Mr. Du Yilong, Ms. Du Jiliu</p>\n<p>The company will release further details following the board’s deliberations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Leads Biolabs-B (09887) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLeads Biolabs-B (09887) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-17 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nanjing Leads Biolabs Co., Ltd. (stock name: Leads Biolabs-B; stock code: 09887) has announced that its board of directors will convene on Friday, 27 March 2026. The agenda includes:</p>\n<p>1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n2. Discussion and potential recommendation of a dividend distribution for shareholders.</p>\n<p>The announcement, dated 17 March 2026, was authorized by Dr. Kang Xiaoqiang, who serves as Chairman, Executive Director and Chief Executive Officer.</p>\n<p>Board composition as at the announcement date:  \n• Executive Directors – Dr. Kang Xiaoqiang, Dr. Lai Shoupeng, Mr. Zuo Honggang  \n• Non-executive Directors – Mr. Zhang Yincheng, Dr. Chen Renhai, Dr. Ni Jia  \n• Independent Non-executive Directors – Dr. Zhang Hongbing, Mr. Du Yilong, Ms. Du Jiliu</p>\n<p>The company will release further details following the board’s deliberations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09887","symbol_name":"维立志博-B","start_time":0,"source_url":"","article_id":"1158227991","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158227991","pubTimestamp":1773737026,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Nanjing Leads Biolabs Co., Ltd. (stock name: Leads Biolabs-B; stock code: 09887) has announced that its board of directors will convene on Friday, 27 March 2026. The agenda includes: 1. Approval and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09887":"维立志博-B"},"translate_title":"Leads Biolabs-B(09887)定于2026年3月27日召开董事会会议，批准2025财年业绩并考虑股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09887":1},"content_text":"Nanjing Leads Biolabs Co., Ltd. (stock name: Leads Biolabs-B; stock code: 09887) has announced that its board of directors will convene on Friday, 27 March 2026. The agenda includes:\n1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n2. Discussion and potential recommendation of a dividend distribution for shareholders.\nThe announcement, dated 17 March 2026, was authorized by Dr. Kang Xiaoqiang, who serves as Chairman, Executive Director and Chief Executive Officer.\nBoard composition as at the announcement date:  \n• Executive Directors – Dr. Kang Xiaoqiang, Dr. Lai Shoupeng, Mr. Zuo Honggang  \n• Non-executive Directors – Mr. Zhang Yincheng, Dr. Chen Renhai, Dr. Ni Jia  \n• Independent Non-executive Directors – Dr. Zhang Hongbing, Mr. Du Yilong, Ms. Du Jiliu\nThe company will release further details following the board’s deliberations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158227991","isCrawlerRequest":true}